Latest filings (excl ownership)
15-12B
Securities registration termination
15 Oct 21
EFFECT
Notice of effectiveness
7 Oct 21
EFFECT
Notice of effectiveness
7 Oct 21
EFFECT
Notice of effectiveness
7 Oct 21
25-NSE
Exchange delisting
5 Oct 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 21
POS AM
Prospectus update (post-effective amendment)
5 Oct 21
POS AM
Prospectus update (post-effective amendment)
5 Oct 21
POS AM
Prospectus update (post-effective amendment)
5 Oct 21
8-K
Completion of Acquisition or Disposition of Assets
5 Oct 21
425
Business combination disclosure
13 Sep 21
8-K
Submission of Matters to a Vote of Security Holders
8 Sep 21
425
Business combination disclosure
31 Aug 21
425
Business combination disclosure
30 Aug 21
425
Business combination disclosure
30 Aug 21
8-K
Other Events
30 Aug 21
425
Business combination disclosure
30 Aug 21
425
Business combination disclosure
30 Aug 21
425
Business combination disclosure
26 Aug 21
425
Business combination disclosure
26 Aug 21
425
Business combination disclosure
12 Aug 21
425
Business combination disclosure
6 Aug 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
425
Business combination disclosure
5 Aug 21
8-K
Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Update
5 Aug 21
425
Business combination disclosure
2 Aug 21
DEFM14A
Proxy related to merger
29 Jul 21
425
Business combination disclosure
26 Jul 21
8-K
Strongbridge Biopharma plc Announces Dates of Special Shareholder Meetings
26 Jul 21
UPLOAD
Letter from SEC
16 Jul 21
425
Business combination disclosure
7 Jul 21
8-K
Other Events
7 Jul 21
CORRESP
Correspondence with SEC
25 Jun 21
425
Business combination disclosure
25 May 21
425
Business combination disclosure
24 May 21
Latest ownership filings
SC 13G/A
ORBIMED ADVISORS LLC
11 Feb 22
SC 13D/A
CAXTON CORP
5 Jan 22
4
Bruce Kovner
5 Jan 22
SC 13D/A
Growth Equity Opportunities Fund III, LLC
25 Oct 21
4
Scott L. Wilhoit
6 Oct 21
4
Richard S Kollender
6 Oct 21
4
Fredric J. Cohen
6 Oct 21
4
JOHN JOHNSON
6 Oct 21
4
Hilde H Steineger
6 Oct 21
4
Marten Steen
6 Oct 21
4
JEFFREY W SHERMAN
6 Oct 21
4
Garheng Kong
6 Oct 21
4
DAVID N GILL
6 Oct 21
4
STEPHEN J LONG
6 Oct 21
4
Scott L. Wilhoit
5 Oct 21
4
STEPHEN J LONG
5 Oct 21
4
Richard S Kollender
5 Oct 21
4
Fredric J. Cohen
5 Oct 21
4
Marten Steen
5 Oct 21
4
JOHN JOHNSON
5 Oct 21
4
Hilde H Steineger
5 Oct 21
4
JEFFREY W SHERMAN
5 Oct 21
4
Garheng Kong
5 Oct 21
4
DAVID N GILL
5 Oct 21
4
Richard S Kollender
8 Sep 21
SC 13G
Stonepine Capital Management, LLC
9 Jul 21
4
JOHN JOHNSON
7 Jul 21
4
Hilde H Steineger
18 May 21
4
Marten Steen
18 May 21
4
JEFFREY W SHERMAN
18 May 21
4
Garheng Kong
18 May 21
4
DAVID N GILL
18 May 21
4
Richard S Kollender
18 May 21
4
Marten Steen
18 May 21
4
Garheng Kong
17 May 21
4
Hilde H Steineger
17 May 21
4
JEFFREY W SHERMAN
17 May 21
4
DAVID N GILL
17 May 21
4
JOHN JOHNSON
9 Apr 21
4
Richard S Kollender
5 Mar 21